BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32913910)

  • 1. Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data.
    Arora C; Kaur D; Lathwal A; Raghava GPS
    Heliyon; 2020 Aug; 6(8):e04811. PubMed ID: 32913910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
    Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
    J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway.
    Lathwal A; Arora C; Raghava GPS
    PLoS One; 2019; 14(9):e0217527. PubMed ID: 31498794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics.
    Dhall A; Patiyal S; Kaur H; Bhalla S; Arora C; Raghava GPS
    Front Genet; 2020; 11():221. PubMed ID: 32273881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
    Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
    Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging.
    Brunner G; Heinecke A; Falk TM; Ertas B; Blödorn-Schlicht N; Schulze HJ; Suter L; Atzpodien J; Berking C
    JNCI Cancer Spectr; 2018 Jul; 2(3):pky032. PubMed ID: 31360859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.
    Farberg AS; Marson JW; Glazer A; Litchman GH; Svoboda R; Winkelmann RR; Brownstone N; Rigel DS;
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):807-823. PubMed ID: 35353350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas.
    Ellis R; Tang D; Nasr B; Greenwood A; McConnell A; Anagnostou ME; Elias M; Verykiou S; Bajwa D; Ewen T; Reynolds NJ; Barrett P; Carling E; Watson G; Armstrong J; Allen AJ; Horswell S; Labus M; Lovat PE
    Br J Dermatol; 2020 Jan; 182(1):156-165. PubMed ID: 31056744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.
    Keller J; Schwartz TL; Lizalek JM; Chang ES; Patel AD; Hurley MY; Hsueh EC
    Cancer Med; 2019 May; 8(5):2205-2212. PubMed ID: 30950242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
    Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
    Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Prognostic Precision in Uveal Melanoma through a Combined Score of Clinical Stage and Molecular Prognostication.
    Stacey AW; Dedania VS; Materin M; Demirci H
    Ocul Oncol Pathol; 2022 Feb; 8(1):35-41. PubMed ID: 35356606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma.
    Hsueh EC; DeBloom JR; Lee JH; Sussman JJ; Covington KR; Caruso HG; Quick AP; Cook RW; Slingluff CL; McMasters KM
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
    Eggermont AMM; Bellomo D; Arias-Mejias SM; Quattrocchi E; Sominidi-Damodaran S; Bridges AG; Lehman JS; Hieken TJ; Jakub JW; Murphree DH; Pittelkow MR; Sluzevich JC; Cappel MA; Bagaria SP; Perniciaro C; Tjien-Fooh FJ; Rentroia-Pacheco B; Wever R; van Vliet MH; Dwarkasing J; Meves A
    Eur J Cancer; 2020 Nov; 140():11-18. PubMed ID: 33032086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
    Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma.
    Dubin DP; Dinehart SM; Farberg AS
    Am J Clin Dermatol; 2019 Dec; 20(6):763-770. PubMed ID: 31359351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.
    Marchetti MA; Coit DG; Dusza SW; Yu A; McLean L; Hu Y; Nanda JK; Matsoukas K; Mancebo SE; Bartlett EK
    JAMA Dermatol; 2020 Sep; 156(9):953-962. PubMed ID: 32745161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging.
    Wisco OJ; Marson JW; Litchman GH; Brownstone N; Covington KR; Martin BJ; Quick AP; Siegel JJ; Caruso HG; Cook RW; Winkelmann RR; Rigel DS
    Melanoma Res; 2022 Apr; 32(2):98-102. PubMed ID: 35254332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
    Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
    Peng Y; Chu Y; Chen Z; Zhou W; Wan S; Xiao Y; Zhang Y; Li J
    World J Surg Oncol; 2020 Jun; 18(1):130. PubMed ID: 32546168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.